5 completed, 3 unknown. 5 Phase 3, 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Unknown 2 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Dipeptiven: new trials by email Literature Review of Dipeptiven trials Research Report on Dipeptiven
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients alanyl-glutamine - Pressure Ulcer | Not applicable | Unknown | Air Force Specialized Hospital, Cairo, Egypt | 200 | 2022-04-01 | 2022-10-19 |
| Glutamine Supplementation and Short-term Mortality in Covid-19 Standard enteral nutrition, Glutamine - Covid19 | Phase 3 | Completed | Assiut University | 60 | 2021-05-30 | 2021-11-05 |
| Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF L-alanyl-L-glutamine dipeptide, Placebo - Coronary Artery Bypass, Cardiopulmonary Bypass | Phase 3 | Completed | National Cardiovascular Center Harapan Kita Hospital Indonesia | 60 | 2021-01-01 | 2023-11-13 |
| Glutamine Effects in Burn Patients Dipeptiven, normal Saline - Drug Effect | Phase 2 / Phase 3 | Unknown | Menoufia University | 60 | 2020-06-01 | 2021-12-01 |
| Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients N2-L-Alanyl-L-Glutamine (Substance) - Enteral Nutrition, Intensive Care Unit | Not applicable | Completed | Centre Hospitalier Universitaire de Besancon | 73 | 2019-11-28 | 2025-01-16 |
| The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition Dipeptiven, normal saline - Multiple Trauma, Critically Ill | Phase 3 | Unknown | Royal Brisbane and Women's Hospital | 88 | 2011-03-01 | 2012-05-24 |
| Efficacy and Mechanisms of GLN Dipeptide in the SICU Glutamine dipeptide with 15% Clinisol, 15% Clinisol - Critical Illness | Phase 3 | Completed | Emory University | 150 | 2006-09-01 | 2018-01-23 |
| Optimized Therapy in Severe Traumatic Brain Injured Patients Dipeptiven - Traumatic Brain Injury, Coma | Phase 4 | Completed | University of Zurich | 12 | 2005-01-01 | 2014-05-06 |
Critical Illness (2) · Brain Injuries, Traumatic (1) · COVID-19 (1) · Coma (1) · Coronary Artery Disease (1) · Multiple Trauma (1) · Pressure Ulcer (1) · Wounds and Injuries (1)
Air Force Specialized Hospital, Cairo, Egypt (1) · Assiut University (1) · Centre Hospitalier Universitaire de Besancon (1) · Emory University (1) · Menoufia University (1) · National Cardiovascular Center Harapan Kita Hospital Indonesia (1) · Royal Brisbane and Women's Hospital (1) · University of Zurich (1)
Egypt (3) · Australia (1) · France (1) · Indonesia (1) · Switzerland (1) · United States (1)
Enas Mogawer, Professor (1) · I Made Adi Parmana (1) · Jeffrey Lipman, MBBCh, MD (1) · John F Stover, MD (1) · Omar Soliman, MD (1) · Thomas R Ziegler, MD (1)
PMID 22102646, PMID 24992948, PMID 26501700
U01DK069322 (1)